Access Statistics for Karl Claxton

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence 1 3 3 108 3 6 15 570
Accounting for timing when assessing health-related policies 0 0 3 10 0 1 11 28
An Economic Approach to Clinical Trial Design and Research Priority Setting 0 0 0 0 2 3 20 864
Appropriate Perspectives for Health Care Decisions 2 10 42 623 10 39 149 1,842
Assessing health opportunity costs for the Indian health care systems 0 1 9 21 0 4 29 76
Assessing the impact of health care expenditures on mortality using cross-country data 0 0 4 80 0 3 18 84
Bayesian Value-of-Information Analysis: An Application to a Policy Model of Alzheimer's Disease 0 0 1 600 1 3 13 2,306
Budget allocation and the revealed social rate of time preference for health 0 0 1 85 1 4 11 343
Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions 0 0 1 45 0 2 4 172
Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data 0 3 16 74 3 10 44 195
Country-level cost-effectiveness thresholds: initial estimates and the need for further research 0 0 7 29 3 4 31 125
Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions 0 0 0 26 0 0 6 132
Defining and characterising structural uncertainty in decision analytic models 1 2 10 177 3 5 37 837
Dimensions of design space: a decision-theoretic approach to optimal research design 0 0 1 52 1 1 3 447
Effects of Fundholding on the Prescribing and Referral Behavior of General Practitioners 0 0 0 0 0 0 0 116
Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13 0 0 2 49 1 3 22 77
Expected health benefits of additional evidence: Principles, methods and applications 0 0 2 22 0 1 17 93
Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling 0 2 7 82 2 6 42 352
Is an ounce of prevention worth a pound of cure? Estimates of the impact of English public health grant on mortality and morbidity 0 2 15 34 7 20 77 158
Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions 0 0 12 342 1 4 30 990
Methods for the estimation of the NICE cost effectiveness threshold 0 0 6 161 2 6 37 682
Modelling the behaviour of general practitioners: a theoretical foundation for studies of fundholding 0 0 1 28 0 0 10 130
Setting research priorities in Global Health:Appraising the value of evidence generation activities to support decision-making in health care 0 0 2 19 0 3 14 32
Supporting the development of an essential health package: principles and initial assessment for Malawi 1 3 13 61 11 19 74 245
The NICE Cost-Effectiveness Threshold: What it is and What that Means 0 1 3 77 2 4 12 255
The Role of Decision Analysis in Structuring the Economic Evaluation of Sequential Clinical Decision Problems 0 0 0 0 0 0 3 202
The value of implementation and the value of information: combined and uneven development 0 0 1 31 1 3 7 137
Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies 0 0 0 31 0 1 4 182
Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? 0 0 6 149 1 5 39 423
Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS 2 8 25 628 10 36 93 1,936
Total Working Papers 7 35 193 3,644 65 196 872 14,031


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A dynamic programming approach to the efficient design of clinical trials 1 1 1 49 1 2 2 119
Accounting for Timing when Assessing Health-Related Policies 0 0 0 4 1 1 11 23
Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals 0 0 2 2 0 1 6 130
Budget allocation and the revealed social rate of time preference for health 0 0 0 0 0 0 3 47
Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions 0 0 0 22 0 0 0 73
CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? 0 0 1 6 0 0 5 25
Comment: Positive tails and normative dogs 0 0 0 1 0 0 3 9
Dangerous omissions: the consequences of ignoring decision uncertainty 0 0 3 5 0 0 4 28
Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion 0 0 0 88 1 1 2 298
Discounting and decision making in the economic evaluation of health‐care technologies 0 0 2 56 0 2 14 243
Discounting in Economic Evaluations 0 0 1 1 0 2 12 26
Evidence synthesis, parameter correlation and probabilistic sensitivity analysis 0 0 1 69 0 0 2 264
How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework 0 0 1 4 0 0 4 9
In recognition of Anthony J. Culyer 0 0 0 17 0 0 4 68
Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations 0 5 8 68 1 7 17 228
OFT, VBP: QED? 0 0 0 41 2 3 8 171
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra 0 0 1 154 2 2 6 588
Real Economics Needs to Reflect Real Decisions 1 2 2 22 1 4 4 80
Redefining the analytical approach to pharmacoeconomics 0 0 0 1 0 0 0 63
Representing uncertainty: the role of cost‐effectiveness acceptability curves 1 1 8 136 4 5 30 416
Selecting treatments: a decision theoretic approach 0 1 2 9 0 1 2 46
Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods 0 0 0 25 0 1 3 89
Social value and individual choice: The value of a choice‐based decision‐making process in a collectively funded health system 0 0 0 0 0 0 0 4
The Value of Further Research: The Added Value of Individual-Participant Level Data 0 0 1 1 1 2 8 10
The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all‐cause and disease specific models of mortality 0 0 1 4 0 0 10 15
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies 1 2 5 197 2 5 16 486
Uncertainty and value of information when allocating resources within and between healthcare programmes 0 1 1 30 0 1 3 81
Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal 0 0 0 1 0 0 1 14
When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development? 0 0 0 0 0 0 3 14
Whither trial‐based economic evaluation for health care decision making? 0 0 2 48 1 1 6 239
Total Journal Articles 4 13 43 1,061 17 41 189 3,906


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Decision Modelling for Health Economic Evaluation 0 0 0 0 27 87 256 3,145
Methods for the Economic Evaluation of Health Care Programmes 0 0 0 0 2 11 52 230
The Humble Economist: Tony Culyer on Health, Health Care and Social Decision Making 0 0 2 4 1 3 11 26
Total Books 0 0 2 4 30 101 319 3,401


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Decision-making with Uncertainty: The Value of Information 0 0 0 12 0 0 4 29
Decision-making with Uncertainty: The Value of Information 0 0 2 32 0 7 19 100
Total Chapters 0 0 2 44 0 7 23 129


Statistics updated 2021-01-03